Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Vandana Singh

TherapeuticsMD Shares Soars After VitaCare Divestiture In $150M Deal

  • TherapeuticsMD Inc (NASDAQ:TXMD) has agreed to divest its VitaCare Prescription Services business to GoodRx Holdings Inc (NASDAQ:GDRX) for $150 million.
  • VitaCare is a consumer-focused digital healthcare platform.
  • TherapeuticsMD will also receive an additional $7 million in cash consideration contingent upon vitaCare's financial performance through 2023. 
  • TXMD will also enter into a long-term services agreement to continue to utilize the vitaCare platform.
  • The transaction is expected to close by Q2 of 2022.
  • VitaCare helps patients understand coverage, identify savings opportunities, and facilitate communication between providers and payors. 
  • The platform also offers a seamless path for filling a prescription, primarily through its network of third-party pharmacies. 
  • GoodRx expects the transaction to contribute under 1% to overall revenue and reduce the adjusted EBITDA margin by approximately 2% in 2022.
  • Price Action: TXMD shares are up 38% at $0.29, while GDRX shares are down 6.70% at $14.91 during the market session on the last check Monday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.